More importantly, the apoptosis rate in HuCCT1 or RBE cells pretreated with ERKi was enhanced after co-culture with CD3/CD28-activated CD8+T cells compared to that in the control group, which was manifested by an increase in tumor cell apoptosis rate detected by the CCK-8 assay or flow cytometry. Here, CD8A is linked to neoplasm.